Bachem Sitemap
- Entering strategic collaboration with Lilly to manufacture oligo-based drug substances
- Bachem achieves sales of half a billion Swiss francs
- Changes to the Bachem CEC and strengthening of the US organization
- Bachem raises CHF 583.5 million through capital increase
- Bachem launches accelerated bookbuilding for approx. 750k new shares
- Extraordinary General Meeting
- Bachem intends a capital increase – construction of additional manufacturing site
- Excellent results for the first half-year 2021
- Bachem reports excellent results in 2020 – Sales exceed 400 million CHF for the first time
- First half of 2020: Record sales and faster growth
- Fiscal Year 2019 – Record year points to increasing growth dynamics
- Half-Year Report 2019: Record sales of 134.5 million CHF and surge in operating income in the first half
- Results of the capital increase
- Key figures for capital increase as announced
- Bachem plans capital increase
- 2018 fiscal year: Record sales and increased operating income
- First half of 2018: Further rise in net profit; delayed sales/EBIT to be made good in second half
- Fiscal year 2017: Continued increase in sales, profitability and earnings
- First half of 2017: New record sales and a solid operating result
- Fiscal year 2016: Another year of strong sales and profit growth
- First half of 2016: New sales record and sharp jump in profits
- Fiscal year 2015: Record sales and creation of new jobs
- First half 2015: Record sales and solid profit growth
- Arg8-Vasopressin
- Triptorelin acetate & Triptorelin pamoate
- Tetracosactide
- Somatostatin
- pTH (1-34) (human) Acetate
- Propofol
- Octreotide acetate
- Leuprolide Acetate
- Lanreotide
- Icatibant Acetate
- Goserelin Acetate
- Gonadorelin Acetate
- Glucagon
- Etomidate
- Carbidopa
- Buserelin
- Bivalirudin
- Atosiban
- Bachem in Oligonucleotides: Interview with Seamus White
- Peptide Synthesis – How are Peptides Made?
- What are Oligos?
- Interview with Robert Yu, CEO of Yuyu Pharma
- Propofol – A Bachem success story
- The weight loss drug Liraglutide
- Interview with Amy Zhang, Head of Supply Chain at Luye Pharma
- Somatostatin Analogs Provide Invaluable Therapeutic Options
- What are somatostatin analogs?
- Meet Bachem: Pascal Hess, Group Leader Generics – Portfolio
- Peptide Trends November 2020
- Bachem ensures global market supply of the active ingredient PROPOFOL from Swiss production site.
- Peptide Trends October 2019
- Bachem Earns Gold Medal Sustainability Rating from EcoVadis
- Bachem Annual General Meeting 2022
- Bachem lays foundations for company’s largest production building
- A world market leader from the Basel region – Bachem celebrates 50 years of company history
- Bachem recognized as a winner at the Swiss Biotech Success Stories Awards 2021
- Bachem celebrates the hire of its 1000th employee at the Bubendorf site
- Bachem announces the launch of their new website
- Annual General Meeting 2021: Change in the Board of Directors of Bachem Holding AG
- Bachem well on track in a challenging market
- Bachem confirms upward trend in its anniversary year
- Bachem expects local sales growth of 6% to 8% in 2011
- Bachem Shows Strength and Continues the Upswing
- Bachem regains the upswing – significantly improved Business Performance in second semester
- Difficult start to first half-year of 2010 for the Bachem Group
- Innovation transforming oligonucleotide manufacturing
- A passion for shaping the future of Bachem: Interview with Diana Rinderle
- The thiol-maleimide reaction downside
- Bachem’s Commitment to Sustainability
- Bachem and Novo Nordisk redesign SPPS for green chemistry
- Bachem innovating through virtual events
- Learn More: A New Turn in Peptide Purification
- Innovation management
- Bachem receives the Top Innovator Award from Alpora
- Learn More: Microspheres and Nanoparticles for Peptide Delivery
- Bachem and GlyTech Nominated for Innovation Award at CPHI Worldwide Forum
- Bachem and BioSpring agree to collaborate on oligonucleotide-peptide conjugates for R&D
- What are Amino Acids?
- What is GMP?
- What are peptides?
- Glossary
- FAQ – frequently asked questions
- Posters
- Publications
- Flyers
- Technical notes
- brochures
- White papers
- Peptide and Amino Acids Calculator
- Oligonucleotide Molecular Weight Calculator
- Net Peptide Content & Concentration Calculator
- Bachem appoints new Head of Group Communications
- Changes to the Bachem Corporate Executive Committee
- Annual General Meeting 2020: Change in the Board of Directors of Bachem Holding AG
- Change on the Bachem Corporate Executive Committee
- Thomas Meier to become new COO of Bachem Group
- Dr. Anne-Kathrin Stoller to assume CMO position at Bachem
- Bachem expands its Corporate Executive Committee
- Dr. Guenther Loidl to assume CTO position at Bachem Group
- Professor Dr. Helma Wennemers nominated for election to Board of Directors
- Dr. José de Chastonay appointed Chief Marketing Officer of Bachem Group
- Change in Bachem’s Corporate Executive Committee
- Stephan Schindler to become new CFO of Bachem Group
- Dr. Jürgen Brokatzky-Geiger elected as a new member of the Board of Directors
- Bachem Enlarges Corporate Executive Committee
- privacy policy
- Imprint
- Legal Statement
- General conditions
- Modern Slavery and Human Trafficking Transparency Statement
- Bachem’s new facilities for large-scale oligonucleotide manufacturing
- Cell-penetrating peptides: a delivery system for oligonucleotides
- Assessing and Influencing ACE2-Mediated COVID-19 Infection
- Bachem’s liraglutide: a high-purity generic for diabetes and weight loss
- Certified and essential: our peptides for in vitro diagnostics
- Meet Bachem: Swetlana Meinhardt, Category Manager
- Peptides unlock doors to understand Parkinson’s disease
- GalNAc: Delivering Promise of Oligonucleotides
- Meet Bachem: Johannes Kremser, Group Leader R&D
- GalNAc conjugates: Delivery service to the liver!
- Peptide Trends February 2021
- Peptide Trends January 2021
- Bachem Expanding into Oligonucleotides
- Peptide Trends October 2020
- Peptide Trends September 2020
- Oligonucleotide Trends September 2020
- Peptide Trends July 2020
- Peptide Trends June 2020
- Peptide Trends May 2020
- BACHEM and JITSUBO enter into exclusive licensing agreement
- Peptide Trends April 2020
- B Brave – Our Commitment
- Peptide Trends March 2020
- Peptide Trends February 2020
- Peptide Trends January 2020
- Oligonucleotide Trends January 2020
- Peptide Trends December 2019
- New Products December 2019
- Peptide Trends November 2019
- Peptide Trends September 2019
- Peptide Trends August 2019
- Peptide Trends July 2019
- Peptide Trends June 2019
- Peptide Trends May 2019
- Peptide Trends April 2019
- Annual General Meeting approves all Board proposals
- Peptide Trends March 2019
- Peptide Trends February 2019
- Peptide Trends January 2019
- Peptide Trends December 2018
- Peptide Trends November 2018
- Bachem: Footprint in Asia
- Bachem site in St Helens, UK, obtains ISO certification
- Peptide Trends April 2018
- Peptide Trends November 2017
- Peptide Trends August 2017
- Peptide Trends July 2017
- Peptide Trends June 2017
- Green Chemistry Award challenge 2017
- Enhancing customer satisfaction and service quality
- Peptide Trends May 2017
- Peptide Trends April 2017
- Peptide Trends March 2017
- Peptide Trends February 2017
- Bachem renews supply contract with AstraZeneca
- Peptide Trends January 2017
- New Product Line: Dye labeled peptides
- What are toxic peptides?
- What is Somatostatin?
- CPHI sustainability award 2016
- Bachem – Reinforced Collaboration with DOTTIKON ES on Novel Amino Acids
- Tau protein and Alzheimer’s disease
- Peptides in molecular imaging and radiopharmaceuticals
- What are antimicrobial peptides?
- What are cyclic peptides?
- Peptide Modifications
- Bachem and ILS extend their collaboration in Japan by an Exclusive Agency Agreement
- GLP-1 in the treatment of Diabetes
- Alzheimer’s disease and the role of beta amyloid
- Cell permeable peptides (CCP)
- Bachem engages Professor Stephen B.H. Kent as Scientific Advisor and enters collaboration with the University of Chicago
- Fiscal year 2014: Renewed sales growth and sharply higher profits
- Bachem acquires American Peptide Company
- Bachem AG and GlyTech, Inc. announce co-promotion agreement
- First half 2014: Strong sales and profit growth / guidance confirmed
- Fiscal Year 2013: Sales beat overall market growth, profits sharply higher
- Renewal of Bachem’s import license to India
- Half-Year Report 2013: Confirmation of upward trend
- Pioneering breakthrough in the chemical synthesis of Interferon β-1a
- Bachem switching from IFRS to Swiss GAAP FER
- 2012 financial year: Bachem clearly tops prior-year results at all levels
- New accreditation certificate of foreign drug manufacturer for Bachem AG received from Japanese ministry of Health, Labour and Welfare.
- New FMOC-TYROSINE derivative available
- Bachem increases working hours at Swiss sites
- Passing of the Baton at Bachem Group
- Bachem renews supply contract with AstraZeneca
- Bachem celebrates 40th anniversary
- Integration of Sochinaz SA completed at mid-year
- US FDA audit
- Professor Dr. Helma Wennemers of the University of Basel receives the Leonidas Zervas Award sponsored by Bachem
- Bachem and Atheris collaborate on Melusine® venom peptide libraries for lead discovery
- Bachem receives Abbott’s supplier excellence award.
- Amino acids chart
- 1H,13C-HSQC HR-MAS NMR as a Tool for Investigating the Quality of Fmoc-AA-Wang Resins for SPPS
- Chromophores/fluorophores: spectral properties and characteristics
- Conversion of a DCHA salt to the free acid
- Peptide solubility
- Reversal of inadvertent oxidation of cys-containing peptides
- Care and Handling of Peptides
- Care and Handling of Amyloid Peptides
- Cysteine Derivatives
- Navigating the benefits and challenges of microspheres and nanoparticles for peptide delivery
- Peptides In Veterinary Medicine
- VIP/PACAP Peptides
- Pseudoproline & Isoacyl dipeptides
- Peptides in cancer research
- Fret Substrates
- Diabetes Peptides
- Peptides in Cosmetics: Pioneering partner for cosmetic peptides
- Click Chemistry: A valuable tool for peptide and protein modification
- Introduction to Cell-Permeable Peptides
- Introduction to Antimicrobial Peptides
- Amyloid Beta Peptides & Alzheimer’s Disease
- A New Turn in Peptide Purification – Peptide Easy Clean